FIND - A global non-profit accelerating the development, evaluation and delivery of high-quality, affordable diagnostic tests for poverty-related diseases

The Foundation for Innovative New Diagnostics (FIND) is leading a consortium, of which Mologic is part, announced today the launch of a new schistosomiasis programme within its neglected tropical diseases (NTD) portfolio.

The programme focuses on developing rapid diagnostic tests (RDTs) for detection of circulating anodic antigen (CAA) in blood and/or urine, to support national control and/or elimination programmes in countries where schistosomiasis is regularly found.

Read more on the official website: